BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24798606)

  • 1. Antigenic phenotype of lung carcinomas: usual spectrum of distribution of thyroid transcription factor-1, cytokeratin 7, cytokeratin 20, and neuron specific enolase--basic immunohistochemical study of 21 cases.
    Kostovski M; Petrushevska G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):199-207. PubMed ID: 24798606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH
    Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
    Jin L; Liu Y; Wang X; Qi X
    Biotech Histochem; 2018; 93(5):364-372. PubMed ID: 29956575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
    Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
    Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
    Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
    Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
    Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry of Cytokeratin 7, Cytokeratin 20 and Thyroid Transcription Factor-1 in Metastatic Carcinoma of Cervical Lymph Node Biopsy for Identification of Pulmonary Origin in Rajavithi Hospital.
    Kuakpaetoon T
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S172-6. PubMed ID: 29927559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
    Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
    Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC; Banner B; Glickman J; Odze RD
    Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.
    Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY
    Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.
    Leite KRM; Mitteldorf CATS; Srougi M; Dall'Oglio MF; Antunes AA; Pontes J; Camara-Lopes LH
    Ann Diagn Pathol; 2008 Aug; 12(4):260-266. PubMed ID: 18620992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
    Ikota H; Tanaka Y; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping.
    Johansson L
    Ann Diagn Pathol; 2004 Oct; 8(5):259-67. PubMed ID: 15494931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
    Resto VA; Krane JF; Faquin WC; Lin DT
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.